Shares of GSK PLC GSK inched up 0.28% to £14.53 Monday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.45% to 8,285.62.

GSK has paid the US financial regulator $20 million to settle charges that its subsidiaries bribed doctors and officials to increase drug sales in China. A filing with the US Securities and ...

Your browser does not support the audio element. MG Motor has released the first set of images and details of an all-new ES5 electric SUV. The ES5 will be a global ...

Investors in GSK plc (Symbol: GSK) saw new options become available today, for the December 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GSK options ...

MG published the first photos of the ES5, a fully electric SUV for global markets. The ES5 will replace the MG ZS EV, with a larger footprint and modern technology. The MG4-based SUV is powered by ...

The update on the GSK-partnered prospect sent Wave’s share price up 63% to almost $14 despite coinciding with news that Takeda has axed a deal for another asset. The ongoing phase 1b/2a study is ...

On Wednesday, the FDA accepted GSK plc’s (NYSE:GSK) marketing application seeking approval for gepotidacin, an investigational, oral antibiotic for adult and adolescent females with ...

GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...

GSK is also seeking damages to compensate for the alleged infringement as well as a “compulsory ongoing licensing fee” for the claimed technologies. “Moderna has reaped billions of dollars in revenue ...

The replacement for the MG ZS EV has debuted as a higher-riding sibling to the rear-wheel-drive MG 4 hatchback.

MG's first all-new roadster in nearly 30 years is capable of 0-100km/h in a claimed 3.2 seconds – but it costs $115,000 in Australia, almost five times the price of an MG 3 city hatch.

Moderna to defend against GSK's claims, spokesperson says GSK seeks unspecified monetary damages from Moderna A spokesperson for Massachusetts-based Moderna said the company was aware of the ...